[1]
M. I. B., “INFLUENCE OF DRUG DELIVERY SYSTEMS ON THE SAFETY AND EFFECTIVENESS PROFILE OF RIBAVIRIN”, Int J App Pharm, vol. 17, no. 2, pp. 65–77, Mar. 2025.